Publications by authors named "Selene Veerman"

Claim this Profile
M
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials.
Houlin Hong, Jack Donlon, Martin Schaefer, Susanne Sarkar, Dragana Bugarski-Kirola, Selene R T Veerman

Clin Drug Investig· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force.
Hélène Verdoux, Robert A Bittner, Alkomiet Hasan, Mishal Qubad, Elias Wagner, Selene Veerman

Eur Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine/norclozapine plasma level ratio and cognitive functioning in patients with schizophrenia spectrum disorders: a systematic review.
Timo T Moscou, Selene R T Veerman

Ther Adv Psychopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial.
Manouk den Toom, Laura Blanken, Inge Horn, Selene Veerman, Joris J B van der Vlugt-Molenaar

Pharmacopsychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial.
Manouk den Toom, Laura Blanken, Inge Horn, Selene Veerman, Joris J B van der Vlugt-Molenaar

Pharmacopsychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
Peter F J Schulte, Selene R T Veerman, Bert Bakker, Jan P A M Bogers, Amy Jongkind

Schizophr Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis.
Priscilla P Oomen, Marieke J H Begemann, Bodyl A Brand, Lieuwe de Haan, Wim Veling, Selene Veerman

Psychol Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.
Selene R T Veerman, Timo Moscou, Jan P A M Bogers, Dan Cohen, Peter F J Schulte

Acta Psychiatr Scand· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine and the risk of haematological malignancies.
Peter Fj Schulte, Dan Cohen, Selene Rt Veerman, Bert Bakker, Jan Pam Bogers

Lancet Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
Selene R T Veerman, Jan P A M Bogers, Dan Cohen, Peter F J Schulte

Pharmacopsychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial.
Iris E Sommer, Shiral S Gangadin, Lot D de Witte, Sanne Koops, C van Baal, Selene R T Veerman

Schizophr Bull· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Marieke J H Begemann, Ilse A Thompson, Wim Veling, Shiral S Gangadin, Chris N W Geraets, Selene R T Veerman

Trials· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine add-on to clozapine treatment for residual negative symptoms of schizophrenia.
Selene Veerman, Peter Schulte, Lieuwe de Haan

Psychopharmacology (Berl)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.
Selene R T Veerman, Peter F J Schulte, Lieuwe de Haan

Drugs· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis